New Drug Targets for Genomic Cancer Therapy Successes, Limitations, Opportunities and Future Challenges

E-ISSN： 1873-5576|1|1|33-47

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.1, Iss.1, 2001-05, pp. : 33-47

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tyrosine kinases as targets in cancer therapy – successes and failures

By Traxler Peter

Expert Opinion on Therapeutic Targets, Vol. 7, Iss. 2, 2003-04 ,pp. : 215-234

Informa Healthcare

Access to resources Recommend Favorite

Challenges and opportunities in the application of pharmacogenetics to antiepileptic drug therapy

By Ferraro Thomas N Dlugos Dennis J Buono Russell J

Pharmacogenomics, Vol. 7, Iss. 1, 2006-01 ,pp. : 89-103

Future Medicine

Access to resources Recommend Favorite

Improving the Development on New Cancer Treatments: Challenges and Opportunities

Drug Design Reviews - Online, Vol. 2, Iss. 5, 2005-08 ,pp. : 341-348

Bentham Science Publishers

Access to resources Recommend Favorite

TRAIL in cancer therapy: present and future challenges

By Mérino Delphine Lalaoui Najoua Morizot Alexandre Solary Eric Micheau Olivier

Expert Opinion on Therapeutic Targets, Vol. 11, Iss. 10, 2007-10 ,pp. : 1299-1314

Informa Healthcare

Access to resources Recommend Favorite

Antidepressant therapy: new targets for drug development

Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 11, 2001-11 ,pp. : 1693-1711

Informa Healthcare

Access to resources Recommend Favorite